deltatrials
Unknown NA INTERVENTIONAL 3-arm NCT00578110

Instrument for Glaucoma Early Detection and Monitoring (IGDM)

SBIR II Instrument for Glaucoma Early Detection and Monitoring

Sponsor: Synabridge Corporation

Conditions Glaucoma
Interventions Glaucoma Diagnosis, Name: Neucodia
Updated 5 times since 2017 Last updated: Apr 1, 2010 Started: Jan 31, 2008 Primary completion: Apr 30, 2010 Completion: Apr 30, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Glaucoma, this trial is ongoing. The trial is conducted by Synabridge Corporation and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status NA

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status NA

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status NA

    First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Synabridge Corporation
  • University of Alabama at Birmingham
  • University of Tennessee
  • Yale University
Data source: Synabridge Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations